Skip to content

EssilorLuxottica Acquires Cellview to Expand Vision Health Technology

๐„๐ฌ๐ฌ๐ข๐ฅ๐จ๐ซ๐‹๐ฎ๐ฑ๐จ๐ญ๐ญ๐ข๐œ๐š ๐€๐œ๐ช๐ฎ๐ข๐ซ๐ž๐ฌ ๐‚๐ž๐ฅ๐ฅ๐ฏ๐ข๐ž๐ฐ ๐ญ๐จ ๐„๐ฑ๐ฉ๐š๐ง๐ ๐•๐ข๐ฌ๐ข๐จ๐ง ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ

๐Ÿ•ถ EssilorLuxottica has acquired Cellview Imaging Inc., a Canadian med-tech start-up specializing in advanced retinal imaging. Cellviewโ€™s ultra-widefield retinal camera, already FDA and CE approved, enables early detection of retinal diseases and is widely used in North America.

๐Ÿ‘ CEO Francesco Milleri stated that integrating Cellviewโ€™s expertise will strengthen EssilorLuxotticaโ€™s ophthalmic technology portfolio and enhance vision health solutions. This move reinforces the companyโ€™s commitment to innovation in eye care.